WO2013003373A1 - Surfaces microstructurées permettant de réduire l'adhérence de bactéries - Google Patents
Surfaces microstructurées permettant de réduire l'adhérence de bactéries Download PDFInfo
- Publication number
- WO2013003373A1 WO2013003373A1 PCT/US2012/044249 US2012044249W WO2013003373A1 WO 2013003373 A1 WO2013003373 A1 WO 2013003373A1 US 2012044249 W US2012044249 W US 2012044249W WO 2013003373 A1 WO2013003373 A1 WO 2013003373A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microstructures
- engineered
- microstructure
- medical article
- unit cell
- Prior art date
Links
- 230000010065 bacterial adhesion Effects 0.000 title claims description 11
- 238000000034 method Methods 0.000 claims abstract description 52
- 239000000463 material Substances 0.000 claims description 44
- 244000005700 microbiome Species 0.000 claims description 17
- 229920001169 thermoplastic Polymers 0.000 claims description 17
- 239000004416 thermosoftening plastic Substances 0.000 claims description 17
- 229920001187 thermosetting polymer Polymers 0.000 claims description 15
- 238000003556 assay Methods 0.000 claims description 12
- 239000004599 antimicrobial Substances 0.000 claims description 10
- 230000002485 urinary effect Effects 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 9
- 230000000845 anti-microbial effect Effects 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 230000003068 static effect Effects 0.000 claims description 8
- 230000002745 absorbent Effects 0.000 claims description 4
- 239000002250 absorbent Substances 0.000 claims description 4
- 239000000560 biocompatible material Substances 0.000 claims description 4
- 229910003460 diamond Inorganic materials 0.000 claims description 3
- 239000010432 diamond Substances 0.000 claims description 3
- 230000032770 biofilm formation Effects 0.000 abstract description 8
- 230000000181 anti-adherent effect Effects 0.000 abstract description 2
- 239000003911 antiadherent Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 126
- 239000011295 pitch Substances 0.000 description 30
- 239000000758 substrate Substances 0.000 description 22
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 20
- 229920000642 polymer Polymers 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 19
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 19
- 239000004205 dimethyl polysiloxane Substances 0.000 description 19
- 238000000576 coating method Methods 0.000 description 17
- -1 poly(dimethylsiloxane) Polymers 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 13
- 238000012876 topography Methods 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000011248 coating agent Substances 0.000 description 11
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 9
- 230000001788 irregular Effects 0.000 description 8
- 239000007943 implant Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000035587 bioadhesion Effects 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- PGFXOWRDDHCDTE-UHFFFAOYSA-N hexafluoropropylene oxide Chemical compound FC(F)(F)C1(F)OC1(F)F PGFXOWRDDHCDTE-UHFFFAOYSA-N 0.000 description 6
- 238000001000 micrograph Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 206010035664 Pneumonia Diseases 0.000 description 5
- 208000009470 Ventilator-Associated Pneumonia Diseases 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 229920005573 silicon-containing polymer Polymers 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000001974 tryptic soy broth Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 238000003794 Gram staining Methods 0.000 description 4
- 206010029803 Nosocomial infection Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 108010046334 Urease Proteins 0.000 description 3
- DOQPXTMNIUCOSY-UHFFFAOYSA-N [4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-[2-(3,4-dimethoxyphenyl)ethyl]-methylazanium;chloride Chemical compound [H+].[Cl-].C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 DOQPXTMNIUCOSY-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 229940116800 covera Drugs 0.000 description 3
- 238000001723 curing Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 238000000206 photolithography Methods 0.000 description 3
- 229920002120 photoresistant polymer Polymers 0.000 description 3
- 238000007747 plating Methods 0.000 description 3
- 229920001610 polycaprolactone Polymers 0.000 description 3
- 239000004632 polycaprolactone Substances 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 108010050327 trypticase-soy broth Proteins 0.000 description 3
- 208000019206 urinary tract infection Diseases 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- UHKPXKGJFOKCGG-UHFFFAOYSA-N 2-methylprop-1-ene;styrene Chemical compound CC(C)=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 UHKPXKGJFOKCGG-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 238000009631 Broth culture Methods 0.000 description 2
- 241000588914 Enterobacter Species 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 241000588748 Klebsiella Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920002732 Polyanhydride Polymers 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000005323 electroforming Methods 0.000 description 2
- 238000004049 embossing Methods 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 150000001282 organosilanes Chemical class 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 2
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OKIYQFLILPKULA-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxybutane Chemical compound COC(F)(F)C(F)(F)C(F)(F)C(F)(F)F OKIYQFLILPKULA-UHFFFAOYSA-N 0.000 description 1
- HDYFAPRLDWYIBU-UHFFFAOYSA-N 1-silylprop-2-en-1-one Chemical class [SiH3]C(=O)C=C HDYFAPRLDWYIBU-UHFFFAOYSA-N 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000989055 Cronobacter Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000495778 Escherichia faecalis Species 0.000 description 1
- 229920002444 Exopolysaccharide Polymers 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 229910001182 Mo alloy Inorganic materials 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607265 Vibrio vulnificus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 229910001093 Zr alloy Inorganic materials 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000013006 addition curing Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001343 alkyl silanes Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- MXZRMHIULZDAKC-UHFFFAOYSA-L ammonium magnesium phosphate Chemical compound [NH4+].[Mg+2].[O-]P([O-])([O-])=O MXZRMHIULZDAKC-UHFFFAOYSA-L 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229920000229 biodegradable polyester Polymers 0.000 description 1
- 239000004622 biodegradable polyester Substances 0.000 description 1
- 229920013641 bioerodible polymer Polymers 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 208000037815 bloodstream infection Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 125000004965 chloroalkyl group Chemical group 0.000 description 1
- FCDDQRGFNZZTMQ-UHFFFAOYSA-N chromium cobalt molybdenum Chemical compound [Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Co].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo] FCDDQRGFNZZTMQ-UHFFFAOYSA-N 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000013005 condensation curing Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229920001973 fluoroelastomer Polymers 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 208000003906 hydrocephalus Diseases 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000006459 hydrosilylation reaction Methods 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000005459 micromachining Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000006082 mold release agent Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- KERTUBUCQCSNJU-UHFFFAOYSA-L nickel(2+);disulfamate Chemical compound [Ni+2].NS([O-])(=O)=O.NS([O-])(=O)=O KERTUBUCQCSNJU-UHFFFAOYSA-L 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000001020 plasma etching Methods 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001245 poly(D,L-lactide-co-caprolactone) Polymers 0.000 description 1
- 229920001432 poly(L-lactide) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001299 polypropylene fumarate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920006216 polyvinyl aromatic Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052990 silicon hydride Inorganic materials 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 210000004215 spore Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01017—Non-adhesive bandages or dressings characterised by the material synthetic, e.g. polymer based
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B17/00—Methods preventing fouling
- B08B17/02—Preventing deposition of fouling or of dust
- B08B17/06—Preventing deposition of fouling or of dust by giving articles subject to fouling a special shape or arrangement
- B08B17/065—Preventing deposition of fouling or of dust by giving articles subject to fouling a special shape or arrangement the surface having a microscopic surface pattern to achieve the same effect as a lotus flower
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C59/00—Surface shaping of articles, e.g. embossing; Apparatus therefor
- B29C59/02—Surface shaping of articles, e.g. embossing; Apparatus therefor by mechanical means, e.g. pressing
- B29C59/022—Surface shaping of articles, e.g. embossing; Apparatus therefor by mechanical means, e.g. pressing characterised by the disposition or the configuration, e.g. dimensions, of the embossments or the shaping tools therefor
- B29C2059/023—Microembossing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C59/00—Surface shaping of articles, e.g. embossing; Apparatus therefor
- B29C59/02—Surface shaping of articles, e.g. embossing; Apparatus therefor by mechanical means, e.g. pressing
- B29C59/04—Surface shaping of articles, e.g. embossing; Apparatus therefor by mechanical means, e.g. pressing using rollers or endless belts
Definitions
- the present disclosure provides a method of making a biofilm adhesion resistant medical article.
- the method includes providing a medical article having a surface comprising a polymeric material.
- the method further includes creating a plurality of engineered microstructures on at least a portion of the surface, wherein each microstructure of the plurality of microstructures includes a base having at least one cross sectional microscale dimension, wherein the aspect ratio of each microstructure is at least 0.5 and no greater than 10, wherein the pitch between adjacent microstructures of the plurality of engineered microstructures is at least 1 time and no greater than 5 times than the smallest cross-sectional dimension, wherein no base of any microstructure includes a cross-sectional dimension greater than 5 microns, and wherein the arrangement of the microstructures on at least a portion of the surface includes a plurality of unit cells, wherein each unit cell of the plurality of unit is at least partially defined by a dimension at least approximating the pitch, and wherein each unit cell comprises a boundary and each unit cell boundary is directly adjacent
- the engineered surface has at least one unit cell defined at least partially by the pitch between adjacent microstructures protruding from or projected into that surface.
- Each unit cell is defined in a single plane and includes at least one microstructure having a single geometry and orientation.
- the unit cells are arranged to be tiled or at least substantially tessellated, such that the boundary region of any one unit cell is directly adjacent to the boundary region of any neighboring unit cell (i.e., there is no deliberate space between the unit cells).
- microorganism is generally used to refer to any prokaryotic or eukaryotic microscopic organism, including without limitation, one or more of bacteria (e.g., motile or vegetative, Gram positive or Gram negative), bacterial spores or endospores, algae, fungi (e.g., yeast, filamentous fungi, fungal spores), mycoplasmas, and protozoa, as well as combinations thereof.
- bacteria e.g., motile or vegetative, Gram positive or Gram negative
- bacterial spores or endospores e.g., algae, fungi (e.g., yeast, filamentous fungi, fungal spores), mycoplasmas, and protozoa, as well as combinations thereof.
- fungi e.g., yeast, filamentous fungi, fungal spores
- mycoplasmas e.g., mycoplasmas
- protozoa protozoa
- Other useful polymers may be thermoplastic or thermoset and include polyurethanes, polyolefins including metallocene polyolefins, polyesters such as elastomeric polyesters (e.g., Hytrel), biodegradable polyesters such as polylactic, polylactic/glycolic acids, copolymers of succinic acid and diols, and the like, fluoropolymers including fluoroelastomers, polyacrylates and polymethacrylates.
- Polyurethanes may be linear and thermoplastic or thermoset.
- suitable biodegradable, bioabsorbable, bioerodible polymers include polycarboxylic acid; polyanhydrides such as maleic anhydride polymers; polyorthoesters; poly-amino acids; polyethylene oxide; polyphosphazenes; polylactic acid, polyglycolic acid, and copolymers and mixtures thereof such as poly(L-lactic acid) (PLLA), poly(D,L,-lactide), poly(lactic acid-co-glycolic acid), and 50/50 weight ratio (D,L-lactide-co-glycolide); polydioxanone; polypropylene fumarate;
- polyanhydrides such as maleic anhydride polymers; polyorthoesters; poly-amino acids; polyethylene oxide; polyphosphazenes; polylactic acid, polyglycolic acid, and copolymers and mixtures thereof such as poly(L-lactic acid) (PLLA), poly(D,L,-lactide), poly(lactic acid-co-
- the microstructures may be directly adjacent to one another, such that the base of a microstructure is directly in contact with the base of an adjacent microstructure.
- the microstructures may be further spaced apart, such that the facets or perimeters of the microstructures are not in contact and are spaced apart by a segment of engineered surface that may, for example, be flat.
- the configuration of microstructures in any given region should be chosen, however, so that the average pitch (i.e., the centroid to centroid distance between adjacent microstructures) is at least as large as the smallest dimension of the smallest microstructure and no greater than 5 times the smallest dimension of the microstructure. Surfaces having pitches outside this range may result in topographies that reduce bioadhesion in certain areas, but at least fail to impede or potentially promote bioadhesion in other areas.
- the arrangement of microstructures 710 on at least a portion of the engineered surface 700 comprises a plurality of unit cells740.
- Each unit cell 740 of the plurality of unit cells 730 exists in a single plane (i.e., two dimensions), is at least partially defined by a dimension at least approximating the pitch, and contains one microstructure. In certain embodiments, the unit cell is at least partially defined by a dimension equal to the pitch. As depicted in Fig. 7a, each unit cell 740 is entirely defined by the pitch between adjacent microstructures.
- Each unit cell includes a boundary 750 defining the perimeter of the unit cell. Each boundary 750 is directly adjacent the boundary of a neighboring unit cell, so that the plurality of unit cells resemble, e.g., a grid or tessellation.
- Biofilm Assay(above) was conducted by analyzing at least five micrographs for each sample.
- the micrographs were obtained using a Leica microscope (Model DM4000B, available from Leica
- a medical article including a surface for reducing bacterial adhesion, the article comprising: an engineered surface comprising a thermoplastic or thermoset material; a plurality of engineered microstructures on at least a portion of the surface, wherein each microstructure of the plurality of microstructures comprises a base having at least one microscale cross-sectional dimension, wherein the aspect ratio of each microstructure is at least 0.5 and no greater than 10, wherein each microstructure of the plurality of engineered microstructures comprises a height greater than 0.5 microns, wherein the pitch between adjacent microstructures of the plurality of engineered microstructures is at least 1 time and no greater than 5 times than the smallest cross-sectional dimension, and wherein no base comprises a cross- sectional dimension greater than 5 microns, and wherein the arrangement of the microstructures on at least a portion of the engineered surface includes a plurality of unit cells, wherein each unit cell of the plurality of unit cells is at least partially defined by a dimension at least approximating the pitch and includes no more
- each microstructure of the plurality of microstructures comprises an elastomeric microstructure.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
L'invention concerne des surfaces à même de résister à la formation de biofilms et de la réduire, en particulier sur des articles médicaux (100). Lesdites surfaces présentent une pluralité d'éléments de microstructure (120) agencés en fonction d'au moins une cellule unitaire (740, 840). L'invention concerne également des procédés permettant de créer des surfaces anti-adhérentes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161501541P | 2011-06-27 | 2011-06-27 | |
US61/501,541 | 2011-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013003373A1 true WO2013003373A1 (fr) | 2013-01-03 |
Family
ID=46579312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/044249 WO2013003373A1 (fr) | 2011-06-27 | 2012-06-26 | Surfaces microstructurées permettant de réduire l'adhérence de bactéries |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013003373A1 (fr) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015156658A1 (fr) * | 2014-04-08 | 2015-10-15 | Equipos Médicos Vizcarra, S.A. | Sonde de foley hydrophobe texturisée à basse adhérence microbienne |
WO2017014936A1 (fr) * | 2015-07-17 | 2017-01-26 | Hoowaki, Llc | Surface microstructurée |
WO2016199054A3 (fr) * | 2015-06-10 | 2017-02-23 | Sabic Global Technologies B.V. | Surfaces en plastique ayant des structures de surface, et procédés de fabrication de ces surfaces |
WO2017209993A1 (fr) * | 2016-05-31 | 2017-12-07 | Carefusion 2200, Inc. | Cathéter de drainage de cavité corporelle à surface microtexturée |
WO2019186312A1 (fr) * | 2018-03-28 | 2019-10-03 | BSH Hausgeräte GmbH | Corps polymère thermoplastique doté d'une structure de surface, procédé pour sa fabrication et appareil électroménager comprenant le corps polymère thermoplastique |
WO2020026061A1 (fr) * | 2018-07-30 | 2020-02-06 | 3M Innovative Properties Company | Articles en mousse antimicrobiens et procédé de fabrication correspondant |
US10590899B2 (en) | 2012-08-01 | 2020-03-17 | 3M Innovative Properties Company | Fuel injectors with improved coefficient of fuel discharge |
CN110891622A (zh) * | 2017-02-17 | 2020-03-17 | Bvw控股公司 | 超疏水表面的选择性终止 |
WO2020106945A1 (fr) * | 2018-11-21 | 2020-05-28 | Bvw Holding Ag | Surface microstructurée |
WO2021033162A1 (fr) | 2019-08-20 | 2021-02-25 | 3M Innovative Properties Company | Surface microstructurée avec élimination accrue des micro-organismes lors du nettoyage, articles et procédés |
WO2021033151A1 (fr) | 2019-08-20 | 2021-02-25 | 3M Innovative Properties Company | Articles médicaux ayant une surface microstructurée présentant une élimination accrue des microorganismes après nettoyage et procédés associés |
WO2021236429A1 (fr) | 2020-05-20 | 2021-11-25 | 3M Innovative Properties Company | Articles médicaux à surface microstructurée |
US11219705B2 (en) | 2014-07-08 | 2022-01-11 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
US11278941B2 (en) | 2017-02-17 | 2022-03-22 | Bvw Holding Ag | Selective termination of superhydrophobic surfaces |
US11357962B2 (en) | 2013-02-13 | 2022-06-14 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US11357965B2 (en) | 2014-04-23 | 2022-06-14 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
WO2022123440A1 (fr) | 2020-12-11 | 2022-06-16 | 3M Innovative Properties Company | Procédé de thermoformage d'un film à surface structurée et articles |
WO2022162528A1 (fr) | 2021-01-28 | 2022-08-04 | 3M Innovative Properties Company | Surface microstructurée à élimination accrue des micro-organismes après nettoyage, articles et procédés |
WO2022162614A1 (fr) | 2021-01-28 | 2022-08-04 | 3M Innovative Properties Company | Articles et compositions antimicrobiennes et procédés associés |
WO2022180466A1 (fr) | 2021-02-23 | 2022-09-01 | 3M Innovative Properties Company | Articles médicaux ayant une surface microstructurée ayant une élimination accrue de micro-organismes lorsqu'ils sont nettoyés et procédés associés |
US20220378622A1 (en) * | 2021-05-26 | 2022-12-01 | Tiburon Technologies, LLC | Biomimetic wound dressing with articulating micropattern |
WO2023042072A1 (fr) | 2021-09-14 | 2023-03-23 | 3M Innovative Properties Company | Articles comprenant une surface incurvée microstructurée et leurs méthodes de fabrication |
WO2023105372A1 (fr) | 2021-12-07 | 2023-06-15 | 3M Innovative Properties Company | Surface microstructurée et articles présentant une moindre visibilité des rayures et procédés associés |
US11744708B2 (en) | 2016-02-16 | 2023-09-05 | Koninklijke Philips N.V. | Surface topographies for altering the physiology of living cells |
US11766822B2 (en) | 2019-08-20 | 2023-09-26 | 3M Innovative Properties Company | Microstructured surface with increased microorganism removal when cleaned, articles and methods |
US11871745B2 (en) | 2021-03-08 | 2024-01-16 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
US11904114B2 (en) | 2015-10-28 | 2024-02-20 | Becton, Dickinson And Company | Extension tubing strain relief |
WO2024030828A3 (fr) * | 2022-08-01 | 2024-04-04 | The Regents Of The University Of California | Système, dispositif et procédé de capteur d'endoprothèse bioélectronique auto-alimenté |
US11965120B2 (en) | 2018-04-05 | 2024-04-23 | 3M Innovative Properties Company | Gel adhesive comprising crosslinked blend of polydiorganosiloxane and acrylic polymer |
WO2024141815A1 (fr) | 2022-12-28 | 2024-07-04 | 3M Innovative Properties Company | Articles multicouches comprenant une couche barrière aux uv |
US12054594B2 (en) | 2021-03-08 | 2024-08-06 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
WO2024213958A1 (fr) | 2023-04-14 | 2024-10-17 | Solventum Intellectual Properties Company | Film polymère multicouche, procédé et articles appropriés pour le thermoformage |
US12134672B2 (en) | 2021-02-03 | 2024-11-05 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
WO2025040970A1 (fr) | 2023-08-21 | 2025-02-27 | 3M Innovative Properties Company | Systèmes, articles solaires et procédés comprenant un film protecteur structuré |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19818956A1 (de) * | 1997-05-23 | 1998-11-26 | Huels Chemische Werke Ag | Materialien mit mikrorauhen, bakterienabweisenden Oberflächen |
DE19950452A1 (de) * | 1999-10-20 | 2001-04-26 | Creavis Tech & Innovation Gmbh | Strukturierte Oberflächen mit zelladhäsions- und zellproliferationshemmenden Eigenschaften |
US6386699B1 (en) | 1998-04-29 | 2002-05-14 | 3M Innovative Properties Company | Embossed receptor media |
US6420622B1 (en) | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
US20030235677A1 (en) | 2002-06-25 | 2003-12-25 | 3M Innovative Properties Company | Complex microstructure film |
WO2004000569A1 (fr) | 2002-06-25 | 2003-12-31 | 3M Innovative Properties Company | Film a microstructure complexe |
US20050089539A1 (en) | 2003-09-09 | 2005-04-28 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
US20060024508A1 (en) * | 2004-07-27 | 2006-02-02 | D Urso Brian R | Composite, nanostructured, super-hydrophobic material |
US20060052452A1 (en) | 2004-09-07 | 2006-03-09 | 3M Innovative Properties Company | Phenolic antiseptic compositions and methods of use |
US20060051385A1 (en) | 2004-09-07 | 2006-03-09 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
US20060051384A1 (en) | 2004-09-07 | 2006-03-09 | 3M Innovative Properties Company | Antiseptic compositions and methods of use |
US7223364B1 (en) | 1999-07-07 | 2007-05-29 | 3M Innovative Properties Company | Detection article having fluid control film |
US20070134784A1 (en) | 2005-12-09 | 2007-06-14 | Halverson Kurt J | Microreplicated microarrays |
US20070231542A1 (en) * | 2006-04-03 | 2007-10-04 | General Electric Company | Articles having low wettability and high light transmission |
US7309519B2 (en) | 1998-10-05 | 2007-12-18 | 3M Innovative Properties Company | Friction control articles for healthcare applications |
US20070298216A1 (en) | 2006-06-23 | 2007-12-27 | 3M Innovative Properties Company | Articles having durable hydrophobic surfaces |
US20080090010A1 (en) | 2004-01-15 | 2008-04-17 | Newsouth Innovations Pty Limited | Hydrophobic Coating Composition |
WO2009152345A1 (fr) | 2008-06-12 | 2009-12-17 | 3M Innovative Properties Company | Compositions hydrophiles biocompatibles |
US20100226943A1 (en) * | 2004-02-17 | 2010-09-09 | University Of Florida | Surface topographies for non-toxic bioadhesion control |
US7879746B2 (en) | 1999-05-21 | 2011-02-01 | 3M Innovative Properties Company | Hydrophilic polypropylene fibers having antimicrobial activity |
-
2012
- 2012-06-26 WO PCT/US2012/044249 patent/WO2013003373A1/fr active Application Filing
Patent Citations (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19818956A1 (de) * | 1997-05-23 | 1998-11-26 | Huels Chemische Werke Ag | Materialien mit mikrorauhen, bakterienabweisenden Oberflächen |
US6420622B1 (en) | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
US20020128578A1 (en) | 1997-08-01 | 2002-09-12 | 3M Innovative Properties Company | Medical article having fluid control film |
US6386699B1 (en) | 1998-04-29 | 2002-05-14 | 3M Innovative Properties Company | Embossed receptor media |
US6867342B2 (en) | 1998-06-18 | 2005-03-15 | 3M Innovative Properties Company | Drug delivery dressing having fluid control film |
US7309519B2 (en) | 1998-10-05 | 2007-12-18 | 3M Innovative Properties Company | Friction control articles for healthcare applications |
US7879746B2 (en) | 1999-05-21 | 2011-02-01 | 3M Innovative Properties Company | Hydrophilic polypropylene fibers having antimicrobial activity |
US7223364B1 (en) | 1999-07-07 | 2007-05-29 | 3M Innovative Properties Company | Detection article having fluid control film |
DE19950452A1 (de) * | 1999-10-20 | 2001-04-26 | Creavis Tech & Innovation Gmbh | Strukturierte Oberflächen mit zelladhäsions- und zellproliferationshemmenden Eigenschaften |
WO2004000569A1 (fr) | 2002-06-25 | 2003-12-31 | 3M Innovative Properties Company | Film a microstructure complexe |
US20030235677A1 (en) | 2002-06-25 | 2003-12-25 | 3M Innovative Properties Company | Complex microstructure film |
US20050089539A1 (en) | 2003-09-09 | 2005-04-28 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
US20080090010A1 (en) | 2004-01-15 | 2008-04-17 | Newsouth Innovations Pty Limited | Hydrophobic Coating Composition |
US20100226943A1 (en) * | 2004-02-17 | 2010-09-09 | University Of Florida | Surface topographies for non-toxic bioadhesion control |
US20060024508A1 (en) * | 2004-07-27 | 2006-02-02 | D Urso Brian R | Composite, nanostructured, super-hydrophobic material |
US20060052452A1 (en) | 2004-09-07 | 2006-03-09 | 3M Innovative Properties Company | Phenolic antiseptic compositions and methods of use |
US20060051384A1 (en) | 2004-09-07 | 2006-03-09 | 3M Innovative Properties Company | Antiseptic compositions and methods of use |
US20060051385A1 (en) | 2004-09-07 | 2006-03-09 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
WO2007070310A2 (fr) | 2005-12-09 | 2007-06-21 | 3M Innovative Properties Company | Micromatrices micro-répliquées |
US20070134784A1 (en) | 2005-12-09 | 2007-06-14 | Halverson Kurt J | Microreplicated microarrays |
US20070231542A1 (en) * | 2006-04-03 | 2007-10-04 | General Electric Company | Articles having low wettability and high light transmission |
US20070298216A1 (en) | 2006-06-23 | 2007-12-27 | 3M Innovative Properties Company | Articles having durable hydrophobic surfaces |
WO2009152345A1 (fr) | 2008-06-12 | 2009-12-17 | 3M Innovative Properties Company | Compositions hydrophiles biocompatibles |
Non-Patent Citations (1)
Title |
---|
XUE-MEI LI ET AL: "What do we need for a superhydrophobic surface? A review on the recent progress in the preparation of superhydrophobic surfaces", WHAT DO WE NEED FOR A SUPERHYDROPHOBIC SURFACE? A REVIEW ON THE RECENT PROGRESS IN THE PREPARATION OF SUPERHYDROPHOBIC SURFACES,, vol. 36, 31 January 2007 (2007-01-31), pages 1350 - 1368, XP002667653 * |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10590899B2 (en) | 2012-08-01 | 2020-03-17 | 3M Innovative Properties Company | Fuel injectors with improved coefficient of fuel discharge |
US12178985B2 (en) | 2013-02-13 | 2024-12-31 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US11357962B2 (en) | 2013-02-13 | 2022-06-14 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
WO2015156658A1 (fr) * | 2014-04-08 | 2015-10-15 | Equipos Médicos Vizcarra, S.A. | Sonde de foley hydrophobe texturisée à basse adhérence microbienne |
US12121691B2 (en) | 2014-04-23 | 2024-10-22 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
US11357965B2 (en) | 2014-04-23 | 2022-06-14 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
US11219705B2 (en) | 2014-07-08 | 2022-01-11 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
WO2016199054A3 (fr) * | 2015-06-10 | 2017-02-23 | Sabic Global Technologies B.V. | Surfaces en plastique ayant des structures de surface, et procédés de fabrication de ces surfaces |
CN107848073A (zh) * | 2015-06-10 | 2018-03-27 | 沙特基础工业全球技术有限公司 | 具有表面结构的塑料表面和制备它们的方法 |
CN107848073B (zh) * | 2015-06-10 | 2019-04-19 | 沙特基础工业全球技术有限公司 | 在固体塑料零件上形成表面结构的方法和包含由该方法形成的固体塑料零件的照明产品 |
WO2017014936A1 (fr) * | 2015-07-17 | 2017-01-26 | Hoowaki, Llc | Surface microstructurée |
US11904114B2 (en) | 2015-10-28 | 2024-02-20 | Becton, Dickinson And Company | Extension tubing strain relief |
US11744708B2 (en) | 2016-02-16 | 2023-09-05 | Koninklijke Philips N.V. | Surface topographies for altering the physiology of living cells |
US10610665B2 (en) | 2016-05-31 | 2020-04-07 | Carefusion 2200, Inc. | Body cavity drainage catheter with microtextured surface |
CN107441568A (zh) * | 2016-05-31 | 2017-12-08 | 康尔福盛2200有限公司 | 具有微纹理化表面的体腔引流导管 |
WO2017209993A1 (fr) * | 2016-05-31 | 2017-12-07 | Carefusion 2200, Inc. | Cathéter de drainage de cavité corporelle à surface microtexturée |
CN110891622A (zh) * | 2017-02-17 | 2020-03-17 | Bvw控股公司 | 超疏水表面的选择性终止 |
US11278941B2 (en) | 2017-02-17 | 2022-03-22 | Bvw Holding Ag | Selective termination of superhydrophobic surfaces |
US11697141B2 (en) | 2017-02-17 | 2023-07-11 | Bvw Holding Ag | Selective termination of superhydrophobic surfaces |
WO2019186312A1 (fr) * | 2018-03-28 | 2019-10-03 | BSH Hausgeräte GmbH | Corps polymère thermoplastique doté d'une structure de surface, procédé pour sa fabrication et appareil électroménager comprenant le corps polymère thermoplastique |
US11965120B2 (en) | 2018-04-05 | 2024-04-23 | 3M Innovative Properties Company | Gel adhesive comprising crosslinked blend of polydiorganosiloxane and acrylic polymer |
WO2020026061A1 (fr) * | 2018-07-30 | 2020-02-06 | 3M Innovative Properties Company | Articles en mousse antimicrobiens et procédé de fabrication correspondant |
WO2020106945A1 (fr) * | 2018-11-21 | 2020-05-28 | Bvw Holding Ag | Surface microstructurée |
CN113164655A (zh) * | 2018-11-21 | 2021-07-23 | Bvw控股公司 | 微结构化表面 |
KR20210095163A (ko) * | 2018-11-21 | 2021-07-30 | 비브이더블유 홀딩 에이쥐 | 마이크로구조 표면 |
US12257138B2 (en) | 2018-11-21 | 2025-03-25 | Bvw Holding Ag | Multifunctional textured device |
KR102771674B1 (ko) * | 2018-11-21 | 2025-02-25 | 비브이더블유 인베스트 에이쥐 | 마이크로구조 표면 |
WO2021033162A1 (fr) | 2019-08-20 | 2021-02-25 | 3M Innovative Properties Company | Surface microstructurée avec élimination accrue des micro-organismes lors du nettoyage, articles et procédés |
US20210177549A1 (en) * | 2019-08-20 | 2021-06-17 | 3M Innovative Properties Company | Medical articles with microstructured surface having increased microorganism removal when cleaned and methods thereof |
WO2021033151A1 (fr) | 2019-08-20 | 2021-02-25 | 3M Innovative Properties Company | Articles médicaux ayant une surface microstructurée présentant une élimination accrue des microorganismes après nettoyage et procédés associés |
US11766822B2 (en) | 2019-08-20 | 2023-09-26 | 3M Innovative Properties Company | Microstructured surface with increased microorganism removal when cleaned, articles and methods |
CN114650887A (zh) * | 2019-08-20 | 2022-06-21 | 3M创新有限公司 | 具有在清洁时微生物去除增加的微结构化表面、制品及方法 |
WO2021236429A1 (fr) | 2020-05-20 | 2021-11-25 | 3M Innovative Properties Company | Articles médicaux à surface microstructurée |
WO2022123440A1 (fr) | 2020-12-11 | 2022-06-16 | 3M Innovative Properties Company | Procédé de thermoformage d'un film à surface structurée et articles |
WO2022162614A1 (fr) | 2021-01-28 | 2022-08-04 | 3M Innovative Properties Company | Articles et compositions antimicrobiennes et procédés associés |
WO2022162528A1 (fr) | 2021-01-28 | 2022-08-04 | 3M Innovative Properties Company | Surface microstructurée à élimination accrue des micro-organismes après nettoyage, articles et procédés |
US12134672B2 (en) | 2021-02-03 | 2024-11-05 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
WO2022180466A1 (fr) | 2021-02-23 | 2022-09-01 | 3M Innovative Properties Company | Articles médicaux ayant une surface microstructurée ayant une élimination accrue de micro-organismes lorsqu'ils sont nettoyés et procédés associés |
US11871745B2 (en) | 2021-03-08 | 2024-01-16 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
US12054594B2 (en) | 2021-03-08 | 2024-08-06 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
US20220378622A1 (en) * | 2021-05-26 | 2022-12-01 | Tiburon Technologies, LLC | Biomimetic wound dressing with articulating micropattern |
WO2023042072A1 (fr) | 2021-09-14 | 2023-03-23 | 3M Innovative Properties Company | Articles comprenant une surface incurvée microstructurée et leurs méthodes de fabrication |
WO2023105372A1 (fr) | 2021-12-07 | 2023-06-15 | 3M Innovative Properties Company | Surface microstructurée et articles présentant une moindre visibilité des rayures et procédés associés |
WO2024030828A3 (fr) * | 2022-08-01 | 2024-04-04 | The Regents Of The University Of California | Système, dispositif et procédé de capteur d'endoprothèse bioélectronique auto-alimenté |
WO2024141815A1 (fr) | 2022-12-28 | 2024-07-04 | 3M Innovative Properties Company | Articles multicouches comprenant une couche barrière aux uv |
WO2024213958A1 (fr) | 2023-04-14 | 2024-10-17 | Solventum Intellectual Properties Company | Film polymère multicouche, procédé et articles appropriés pour le thermoformage |
WO2025040970A1 (fr) | 2023-08-21 | 2025-02-27 | 3M Innovative Properties Company | Systèmes, articles solaires et procédés comprenant un film protecteur structuré |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013003373A1 (fr) | Surfaces microstructurées permettant de réduire l'adhérence de bactéries | |
EP2632613B1 (fr) | Surfaces modifiées pour la réduction de l'adhésion bactérienne | |
Ge et al. | Micro/nano-structured TiO2 surface with dual-functional antibacterial effects for biomedical applications | |
US20090093879A1 (en) | Micro- and nano-patterned surface features to reduce implant fouling and regulate wound healing | |
Lorenzetti et al. | The influence of surface modification on bacterial adhesion to titanium-based substrates | |
US12138952B2 (en) | Nanostructured surfaces | |
Liu et al. | Understanding the role of polymer surface nanoscale topography on inhibiting bacteria adhesion and growth | |
US20210177549A1 (en) | Medical articles with microstructured surface having increased microorganism removal when cleaned and methods thereof | |
WO2022180466A1 (fr) | Articles médicaux ayant une surface microstructurée ayant une élimination accrue de micro-organismes lorsqu'ils sont nettoyés et procédés associés | |
RU2603083C2 (ru) | Устройство для направления миграции клеток и способ направления миграции клеток посредством такого устройства | |
WO2008029612A1 (fr) | Bio-implant | |
Patil et al. | Bioinspired nanostructured bactericidal surfaces | |
Xu et al. | One-step large-scale nanotexturing of nonplanar PTFE surfaces to induce bactericidal and anti-inflammatory properties | |
Oopath et al. | Rose petal mimetic surfaces with antibacterial properties produced using nanoimprint lithography | |
Jeong et al. | Nanostructure-based wettability modification of TiAl6V4 alloy surface for modulating biofilm production: Superhydrophilic, superhydrophobic, and slippery surfaces | |
Bhushan | Bio-and inorganic fouling | |
Martinez et al. | Cell resistant zwitterionic polyelectrolyte coating promotes bacterial attachment: an adhesion contradiction | |
Eduok et al. | Superhydrophobic antibacterial polymer coatings | |
US20070238174A1 (en) | Substrates | |
Shen et al. | Self-Patterned nanoscale topography of thin copolymer films prepared by evaporative assembly-resist early-stage bacterial adhesion | |
Wang | Effect of Aligned Nanoscale Surface Structures on Microbial Adhesion | |
Mishra et al. | Preparation and Characterization of Nanosilica Based Superhydrophobic Antimicrobial Coatings and Evaluation of Bacterial Adhesion on Coated Surface. | |
US20230061211A1 (en) | Artificial Prosthesis and Method for Manufacturing Same | |
WO2014110511A1 (fr) | Barrières protectrices pour la prévention ou la réduction du transfert de micro-organismes | |
Cao | The effects of surface architecture and physics on bacterial biofilm growth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12738660 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12738660 Country of ref document: EP Kind code of ref document: A1 |